Get the Stockscreener App
1.21
0.83%
0.01
After Hours:
1.20
-0.01
-0.83%
Hoth Therapeutics Inc stock is traded at $1.21, with a volume of 46,883.
It is up +0.83% in the last 24 hours and down -12.95% over the past month.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).
See More
Previous Close:
$1.20
Open:
$1.2
24h Volume:
46,883
Relative Volume:
0.04
Market Cap:
$18.77M
Revenue:
-
Net Income/Loss:
$-7.51M
P/E Ratio:
-0.9167
EPS:
-1.32
Net Cash Flow:
$-8.02M
1W Performance:
+11.52%
1M Performance:
-12.95%
6M Performance:
+42.81%
1Y Performance:
+45.78%
1-Day Range:
$1.19
$1.23
1-Week Range:
$1.0574
$1.2398
52-Week Range:
$0.6554
$3.80
Hoth Therapeutics Inc Stock (HOTH) Company Profile
Name
Hoth Therapeutics Inc
Sector
Industry
Phone
(646)756-2997
Address
1177 AVENUE OF THE AMERICAS, NEW YORK, NY
Compare HOTH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOTH
Hoth Therapeutics Inc
|
1.21 | 18.62M | 0 | -7.51M | -8.02M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Hoth Therapeutics Inc Stock (HOTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-19 | Initiated | The Benchmark Company | Speculative Buy |
Hoth Therapeutics Inc Stock (HOTH) Latest News
Bearish Setup: Is Hoth Therapeutics Inc. stock trading near support levelsQuarterly Risk Review & Real-Time Volume Analysis Alerts - moha.gov.vn
What technical signals suggest for Hoth Therapeutics Inc. stockWeekly Trade Report & Fast Entry Momentum Trade Alerts - newser.com
Will Hoth Therapeutics Inc. stock maintain growth storyJuly 2025 Reactions & Consistent Profit Trade Alerts - newser.com
Hoth Therapeutics joins NVIDIA Connect Program to enhance AI research By Investing.com - Investing.com Nigeria
Hoth Therapeutics joins NVIDIA Connect Program to enhance AI research - Investing.com
Hoth Therapeutics accepted into Nvidia Connect Program, expanding its AI and accelerated computing capabilities - MarketScreener
Hoth Therapeutics (NASDAQ: HOTH) to Expand AI Drug R&D via NVIDIA Connect Program - Stock Titan
Can Hoth Therapeutics Inc. stock deliver surprise earnings beat2025 Bull vs Bear & Daily Market Momentum Tracking - newser.com
Can Hoth Therapeutics Inc. stock maintain growth trajectoryQuarterly Profit Review & High Accuracy Buy Signal Tips - newser.com
Is Hoth Therapeutics Inc a good long term investmentVolume Weighted Average Price & Free Superior Profit Margins - earlytimes.in
Can Hoth Therapeutics Inc. stock deliver consistent earnings growth2025 EndofYear Setup & Free High Return Stock Watch Alerts - newser.com
What moving averages say about Hoth Therapeutics Inc.Earnings Beat & Target Return Focused Picks - newser.com
Published on: 2025-11-19 05:13:43 - newser.com
Will Hoth Therapeutics Inc. stock pay special dividendsJuly 2025 EndofMonth & Capital Protection Trading Alerts - newser.com
D. Boral Capital Maintains Hoth Therapeutics (HOTH) Buy Recommendation - Nasdaq
Why Hoth Therapeutics Inc. stock remains on buy listsRisk Management & Consistent Profit Alerts - newser.com
How to build a dashboard for Hoth Therapeutics Inc. stockJuly 2025 Setups & Expert Curated Trade Setups - newser.com
Will Hoth Therapeutics Inc. rebound enough to break evenGold Moves & Low Risk High Reward Trade Ideas - newser.com
Hoth Therapeutics Inc Stock (HOTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
1.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):